Loscocco相关文献与解析，生知库 | 链接生命科学的每一步

Baratè, Claudia; Scortechini, Ilaria; Ciofini, Sara; Picardi, Paola; Angeletti, Ilaria; Loscocco, Federica; Sanna, Alessandro; Isidori, Alessandro; Grazioli, Elisa; Sportoletti, Paolo

白血病

细胞生物学

发表日期：2026

文献求助收藏

Neutrophil-to-Lymphocyte ratio as surrogate for JAK2(V617F) suppression and event-free survival in polycythemia vera

中性粒细胞与淋巴细胞比值作为真性红细胞增多症中JAK2(V617F)抑制和无事件生存期的替代指标

期刊:Blood Cancer Journal

影响因子:11.6

doi:10.1038/s41408-025-01317-6

Barbui, Tiziano; Ghirardi, Arianna; Empson, Victoria; Fenili, Francesca; Loscocco, Giuseppe Gaetano; Condorelli, Annalisa; Iurlo, Alessandra; Cattaneo, Daniele; Rossi, Elena; De Stefano, Valerio; Guglielmelli, Paola; Klade, Christoph; Gisslinger, Heinz; Rambaldi, Alessandro; Scandura, Joseph M; Vannucchi, Alessandro Maria

TP53 Mutations in Myeloproliferative Neoplasms: Context-Dependent Evaluation of Prognostic Relevance

骨髓增生性肿瘤中的TP53突变：预后相关性的背景依赖性评估

期刊:American Journal of Hematology

影响因子:9.9

doi:10.1002/ajh.27609

Tefferi, Ayalew; Abdelmagid, Maymona; Loscocco, Giuseppe G; Fathima, Saubia; Begna, Kebede H; Al-Kali, Aref; Foran, James; Palmer, Jeanne; Badar, Talha; Patnaik, Mrinal M; Reichard, Kaaren K; He, Rong; Zepeda Mendoza, Cinthya J; Shah, Mithun; Orazi, Attilio; Arber, Daniel A; Pardanani, Animesh; Vannucchi, Alessandro M; Hiwase, Devendra; Gangat, Naseema; Guglielmelli, Paola

Triple A Plus (AAA (+)) Survival Prediction Model for Essential Thrombocythemia: Analysis Involving 7308 Patients

原发性血小板增多症的AAA+（AAA（+））生存预测模型：一项涉及7308名患者的分析

期刊:American Journal of Hematology

影响因子:9.9

doi:10.1002/ajh.70065

Tefferi, Ayalew; Loscocco, Giuseppe G; Rokach, Lior; Tadmor, Tamar; Faldu, Priyansh; Melamed, Guy; Alapi, Hilel; Abdelmagid, Maymona; Abdelaziz, Rania M; Yousuf, Muhammad; Nakhleh, Merry; Pardanani, Animesh; Begna, Kebede H; Patnaik, Mirnal M; Szuber, Natasha; Carobbio, Alessandra; Barbui, Tiziano; Reichard, Kaaren K; He, Rong; Guglielmelli, Paola; Gangat, Naseema; Vannucchi, Alessandro M

血小板

发表日期：2025

文献求助收藏

Targeted Therapies in Myelofibrosis: Present Landscape, Ongoing Studies, and Future Perspectives

骨髓纤维化靶向治疗：现状、正在进行的研究和未来展望

期刊:American Journal of Hematology

影响因子:9.9

doi:10.1002/ajh.27658

Loscocco, Giuseppe G; Guglielmelli, Paola

发表日期：2025

文献求助收藏

One thousand patients with essential thrombocythemia: the Florence-CRIMM experience

一千例原发性血小板增多症患者：佛罗伦萨-CRIMM的经验

期刊:Blood Cancer Journal

影响因子:11.6

doi:10.1038/s41408-023-00968-7

Loscocco, Giuseppe G; Gesullo, Francesca; Capecchi, Giulio; Atanasio, Alessandro; Maccari, Chiara; Mannelli, Francesco; Vannucchi, Alessandro M; Guglielmelli, Paola

Chronic myeloproliferative neoplasms with concomitant CALR mutation and BCR::ABL1 translocation: diagnostic and therapeutic implications of a rare hybrid disease

伴有CALR突变和BCR::ABL1易位的慢性骨髓增生性肿瘤：一种罕见混合疾病的诊断和治疗意义

期刊:Frontiers in Cell and Developmental Biology

影响因子:4.3

doi:10.3389/fcell.2024.1391078

Zanelli, Magda; Fragliasso, Valentina; Loscocco, Giuseppe Gaetano; Sanguedolce, Francesca; Broggi, Giuseppe; Zizzo, Maurizio; Palicelli, Andrea; Ricci, Stefano; Ambrogi, Elisa; Martino, Giovanni; Aversa, Sara; Coppa, Francesca; Gentile, Pietro; Gozzi, Fabrizio; Caltabiano, Rosario; Koufopoulos, Nektarios; Asaturova, Aleksandra; Cimino, Luca; Cavazza, Alberto; Orcioni, Giulio Fraternali; Ascani, Stefano

Imatinib is effective in some PDGFRA/B-negative hypereosinophilic syndromes: A step closer to unveiling underlying mechanisms

伊马替尼对某些PDGFRA/B阴性嗜酸性粒细胞增多症有效：揭示其潜在机制又向前迈进了一步

期刊:British Journal of Haematology

影响因子:3.8

doi:10.1111/bjh.19853

Loscocco, Giuseppe G; Helbig, Grzegorz

Editorial: Biological and clinical implications of the mutational landscape in myeloproliferative neoplasms

社论：骨髓增生性肿瘤突变图谱的生物学和临床意义

期刊:Frontiers in Oncology

影响因子:3.3

doi:10.3389/fonc.2024.1454837

Loscocco, Giuseppe Gaetano; Mora, Barbara; Gangat, Naseema

Management of infections for patient treated with ibrutinib in clinical practice

临床实践中接受伊布替尼治疗患者的感染管理

期刊:Frontiers in Oncology

影响因子:3.3

doi:10.3389/fonc.2024.1428464

Baratè, Claudia; Scortechini, Ilaria; Ciofini, Sara; Picardi, Paola; Angeletti, Ilaria; Loscocco, Federica; Sanna, Alessandro; Isidori, Alessandro; Sportoletti, Paolo

炎症/感染

发表日期：2024

文献求助收藏

Fitness in CLL

慢性淋巴细胞白血病中的健身

Neutrophil-to-Lymphocyte ratio as surrogate for JAK2(V617F) suppression and event-free survival in polycythemia vera

中性粒细胞与淋巴细胞比值作为真性红细胞增多症中JAK2(V617F)抑制和无事件生存期的替代指标

TP53 Mutations in Myeloproliferative Neoplasms: Context-Dependent Evaluation of Prognostic Relevance

骨髓增生性肿瘤中的TP53突变：预后相关性的背景依赖性评估

Triple A Plus (AAA (+)) Survival Prediction Model for Essential Thrombocythemia: Analysis Involving 7308 Patients

原发性血小板增多症的AAA+（AAA（+））生存预测模型：一项涉及7308名患者的分析

Targeted Therapies in Myelofibrosis: Present Landscape, Ongoing Studies, and Future Perspectives

骨髓纤维化靶向治疗：现状、正在进行的研究和未来展望

One thousand patients with essential thrombocythemia: the Florence-CRIMM experience

一千例原发性血小板增多症患者：佛罗伦萨-CRIMM的经验

Chronic myeloproliferative neoplasms with concomitant CALR mutation and BCR::ABL1 translocation: diagnostic and therapeutic implications of a rare hybrid disease

伴有CALR突变和BCR::ABL1易位的慢性骨髓增生性肿瘤：一种罕见混合疾病的诊断和治疗意义

Imatinib is effective in some PDGFRA/B-negative hypereosinophilic syndromes: A step closer to unveiling underlying mechanisms

伊马替尼对某些PDGFRA/B阴性嗜酸性粒细胞增多症有效：揭示其潜在机制又向前迈进了一步

Editorial: Biological and clinical implications of the mutational landscape in myeloproliferative neoplasms

社论：骨髓增生性肿瘤突变图谱的生物学和临床意义

Management of infections for patient treated with ibrutinib in clinical practice

临床实践中接受伊布替尼治疗患者的感染管理